A 20-Year Experience With Percutaneous Resection of Upper Tract Transitional Carcinoma: Is There an Oncologic Benefit With Adjuvant Bacillus Calmette Guérin Therapy?
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PERCUTANEOUS NEPHROSCOPIC MANAGEMENT OF UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA: RECURRENCE AND LONG-TERM FOLLOWUPJournal of Urology, 2004
- Percutaneous Management Of Renal Pelvic Urothelial Tumors: Long-Term FollowupJournal of Urology, 2003
- Long-term Experience With Bacillus Calmette-Guerin Therapy of Upper Urinary Tract Transitional Cell Carcinoma in Patients Not Eligible for SurgeryJournal of Urology, 2002
- Transitional-Cell Carcinoma of the Renal Pelvis: Ureteroscopic and Percutaneous ApproachJournal of Endourology, 2001
- PRIMARY PERCUTANEOUS APPROACH TO UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMAUrologic Clinics of North America, 2000
- Ureteroscopic Treatment and Surveillance of Upper Urinary Tract Transitional Cell CarcinomaJournal of Urology, 1997
- Superficial Bladder Cancer Treated with Bacillus Calmette-Guerin: A Multivariate Analysis of Factors Affecting Tumor ProgressionJournal of Urology, 1989
- Percutaneous Management of Upper Tract Transitional Cell CarcinomaJournal of Urology, 1986
- Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary reportCancer, 1985
- Papillomatous Tumor of the Renal Pelvis Associated with Similar Tumors of the Ureter and Bladder. Review of Literature and Report of Two CasesJournal of Urology, 1934